62 related articles for article (PubMed ID: 11006485)
1. Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties.
Wichmann J; Adam G; Röver S; Hennig M; Scalone M; Cesura AM; Dautzenberg FM; Jenck F
Eur J Med Chem; 2000 Sep; 35(9):839-51. PubMed ID: 11006485
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics.
Ding H; Kiguchi N; Dobbins M; Romero-Sandoval EA; Kishioka S; Ko MC
Drugs; 2023 Jun; 83(9):771-793. PubMed ID: 37209211
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
El Daibani A; Che T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856
[TBL] [Abstract][Full Text] [Related]
4. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.
De Neve J; Barlow TMA; Tourwé D; Bihel F; Simonin F; Ballet S
RSC Med Chem; 2021 Jun; 12(6):828-870. PubMed ID: 34223156
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics.
Kiguchi N; Ding H; Kishioka S; Ko MC
Curr Top Med Chem; 2020; 20(31):2878-2888. PubMed ID: 32384033
[TBL] [Abstract][Full Text] [Related]
7. NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.
Targowska-Duda KM; Ozawa A; Bertels Z; Cippitelli A; Marcus JL; Mielke-Maday HK; Zribi G; Rainey AN; Kieffer BL; Pradhan AA; Toll L
Neuropharmacology; 2020 Jun; 170():108029. PubMed ID: 32278976
[TBL] [Abstract][Full Text] [Related]
8. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
Aziz AM; Brothers S; Sartor G; Holm L; Heilig M; Wahlestedt C; Thorsell A
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3553-63. PubMed ID: 27515665
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.
Toll L; Bruchas MR; Calo' G; Cox BM; Zaveri NT
Pharmacol Rev; 2016 Apr; 68(2):419-57. PubMed ID: 26956246
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.
Zaveri NT
J Med Chem; 2016 Aug; 59(15):7011-28. PubMed ID: 26878436
[TBL] [Abstract][Full Text] [Related]
11. The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
Lutfy K; Zaveri NT
Prog Mol Biol Transl Sci; 2016; 137():149-81. PubMed ID: 26810001
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
Saccone PA; Zelenock KA; Lindsey AM; Sulima A; Rice KC; Prinssen EP; Wichmann J; Woods JH
J Pharmacol Exp Ther; 2016 Apr; 357(1):17-23. PubMed ID: 26801398
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.
Sartor GC; Powell SK; Wiedner HJ; Wahlestedt C; Brothers SP
Brain Res; 2016 Feb; 1632():34-41. PubMed ID: 26657743
[TBL] [Abstract][Full Text] [Related]
14. Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
Chang SD; Brieaddy LE; Harvey JD; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA; Decker AM; McElhinny CJ; Zhong D; Peterson EE; Navarro HA; Bruchas MR; Carroll FI
ACS Chem Neurosci; 2015 Dec; 6(12):1956-64. PubMed ID: 26367173
[TBL] [Abstract][Full Text] [Related]
15. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
Daga PR; Polgar WE; Zaveri NT
J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.
Rizzi A; Malfacini D; Cerlesi MC; Ruzza C; Marzola E; Bird MF; Rowbotham DJ; Salvadori S; Guerrini R; Lambert DG; Calo G
Br J Pharmacol; 2014 Sep; 171(17):4138-53. PubMed ID: 24903280
[TBL] [Abstract][Full Text] [Related]
17. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
Journigan VB; Polgar WE; Khroyan TV; Zaveri NT
Bioorg Med Chem; 2014 Apr; 22(8):2508-16. PubMed ID: 24657054
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
